Login / Signup
Deciding who to treat with biologic disease-modifying antirheumatic drugs in axial spondyloarthritis.
Daniel Wendling
Philippe Goupille
Published in:
Immunotherapy (2020)
Keyphrases
</>
rheumatoid arthritis
disease activity
ankylosing spondylitis
rheumatoid arthritis patients
systemic lupus erythematosus